Literature DB >> 6319701

Synthesis of imidazo[1,2-a]pyrazine derivatives with uterine-relaxing, antibronchospastic, and cardiac-stimulating properties.

C Sablayrolles, G H Cros, J C Milhavet, E Rechenq, J P Chapat, M Boucard, J J Serrano, J H McNeill.   

Abstract

A series of imidazo[1,2-alpha]pyrazine derivatives was synthesized by condensation of alpha-halogenocarbonyl compounds and aminopyrazines. Various compounds resulted from competitive reactions or reagent isomerization and demonstrated in vitro uterine-relaxing and in vivo antibronchospastic activities. On isolated atria, 5-bromoimidazo-[1,2-alpha]pyrazine showed positive chronotropic and inotropic properties; the latter was associated with an increase in the cyclic AMP tissue concentration. Potentiation of the isoproterenol positive inotropic effect of 5-bromoimidazo[1,2-alpha]pyrazine and the lack of blockade of the 5-bromoimidazo[1,2-alpha]pyrazine positive inotropic effect by propranolol suggested phosphodiesterase-inhibiting properties.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319701     DOI: 10.1021/jm00368a018

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Microwave-assisted synthesis of a 3-aminoimidazo[1,2-a]-pyridine/pyrazine library by fluorous multicomponent reactions and subsequent cross-coupling reactions.

Authors:  Yimin Lu; Wei Zhang
Journal:  QSAR Comb Sci       Date:  2004

Review 2.  Emerging approaches for the syntheses of bicyclic imidazo[1,2-x]-heterocycles.

Authors:  Christopher Hulme; Yeon-Sun Lee
Journal:  Mol Divers       Date:  2008-04-12       Impact factor: 2.943

3.  Evaluation of the relaxant effects of SCA40, a novel charybdotoxin-sensitive potassium channel opener, in guinea-pig isolated trachealis.

Authors:  F Laurent; A Michel; P A Bonnet; J P Chapat; M Boucard
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

4.  Investigation of rotameric conformations of substituted imidazo-[1,2-a]pyrazine: experimental and theoretical approaches.

Authors:  Gulshan Kumar; Richa Goel; Kamaldeep Paul; Vijay Luxami
Journal:  RSC Adv       Date:  2018-03-07       Impact factor: 4.036

5.  2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion.

Authors:  James R Sayer; Karin Walldén; Thomas Pesnot; Frederick Campbell; Paul J Gane; Michela Simone; Hans Koss; Floris Buelens; Timothy P Boyle; David L Selwood; Gabriel Waksman; Alethea B Tabor
Journal:  Bioorg Med Chem       Date:  2014-09-28       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.